what's the difference tirzepatide and semaglutide or different types of tirzepatide vs.

B.BuczyskaA.AdamskaA.et al (2022)

The compounding question is not whether semaglutide has risks

11.8% average weight loss as monotherapy in Phase 3 trialsclinically significant and comparable to first-generation GLP-1 medications

Weeks 2-4: When Weight Loss Becomes Measurable Most clinical data shows meaningful weight loss beginning around week 3-4 of consistent semaglutide use, as cumulative metabolic changes take hold

Compared with liraglutide, more semaglutide users achieved weight loss greater than five or 10 percent

Most GLP-1 patients are underestimating both and the gap is where muscle loss and dehydration happen